Lv51
1340 积分 2024-02-08 加入
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial
5小时前
已完结
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
2天前
已完结
Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma
5天前
已完结
CD70-targeted iPSC-derived CAR-NK cells display potent function against tumors and alloreactive T cells
5天前
已完结
CAR-engineered NK cells versus CAR T cells in treatment of glioblastoma; strength and flaws
5天前
已完结
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial
5天前
已完结
Mesothelin antigen density influences anti-mesothelin chimeric antigen receptor T cell cytotoxicity
24天前
已完结
Mesothelin-targeted CAR-T therapy combined with irinotecan for the treatment of solid cancer
24天前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
1个月前
已完结
CD70‐silenced dendritic cells induce immune tolerance in immune thrombocytopenia patients
1个月前
已完结
皖公网安备34019202002308
